Madam Chair, the work we have done to procure the diversity of vaccines in our vaccine portfolio is truly a great thing for Canadians. In fact, it means that Canadians will have access to a variety of different kinds of vaccines. Provinces and territories, as well, will have access to a variety of different kinds of vaccines to deliver in their health care jurisdictional authority.
Our regulators are working on the three companies that have submitted to date to ensure that we can approve them quickly, working with our U.S. counterparts and our EU counterparts. As soon as a vaccine is shown to be safe in Canada, we will make sure that Canadians have access to that vaccine.